スピルリナの世界市場:種類別(アルスロスピラプラテンシス、アルスロスピラマキシマ)、用途別(栄養補助食品、化粧品、食品および飲料、動物飼料、その他)、製剤別(粉末、錠剤・カプセル、液体、顆粒、ゲル化剤)...市場調査レポートについてご紹介

【英文タイトル】Spirulina Market by Type (Arthrospira Platensis and Arthrospira Maxima), Application (Nutraceuticals, Cosmetics, Food & Beverages, Animal Feed, and Others), and Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent): Global Opportunity Analysis and Industry Forecast, 2019–2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings

2.1.1. Top impacting factors
2.1.2. Top investment pockets

2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Spirulina Market

3.3.1. Low-to-high bargaining power of suppliers
3.3.2. Moderate-to-high threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Low-to-moderate bargaining power of buyers

3.4. Pricing Analysis

3.4.1. Pricing Analysis, By Region, 2018 & 2025

3.5. Value Chain Analysis
3.6. Impact of government regulations on global spirulina market
3.7. Industry Pain point analysis
3.8. Patent Analysis

3.8.1. By Region (2016-2018)
3.8.2. By Applicant

3.9. Case Studies

3.9.1. Case Study 01

3.10. Market dynamics

3.10.1. Drivers

3.10.1.1. Rise in demand for natural ingredient
3.10.1.2. Promotion of the production of spirulina by government
3.10.1.3. R&D of spirulina as commercial products

3.10.2. Restraints

3.10.2.1. Impact on spirulina production due to climate change

3.10.3. Opportunities

3.10.3.1. Untapped markets in the developing countries
3.10.3.2. Easy to cultivate due to development in cultivation technology

CHAPTER 4: SPIRULINA MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Arthrospira Platensis

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Arthrospira Maxima

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

CHAPTER 5: SPIRULINA MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Nutraceuticals

5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast
5.2.3. Market analysis, by country

5.3. Cosmetics

5.3.1. Key market trends and opportunities
5.3.2. Market size and forecast
5.3.3. Market analysis, by country

5.4. Food and Beverages

5.4.1. Key market trends and opportunities
5.4.2. Market size and forecast
5.4.3. Market analysis, by country

5.5. Animal Feed

5.5.1. Key market trends and opportunities
5.5.2. Market size and forecast
5.5.3. Market analysis, by country

5.6. Other applications

5.6.1. Key market trends and opportunities
5.6.2. Market size and forecast
5.6.3. Market analysis, by country

CHAPTER 6: SPIRULINA MARKET, BY DRUG FORMULATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Powder

6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast
6.2.3. Market analysis, by country

6.3. Tablet & Capsule

6.3.1. Key market trends and opportunities
6.3.2. Market size and forecast
6.3.3. Market analysis, by country

6.4. Liquid

6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast
6.4.3. Market analysis, by country

6.5. Granule & Gelling Agent

6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast
6.5.3. Market analysis, by country

CHAPTER 7: SPIRULINA MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities
7.2.2. North America market size and forecast, by type
7.2.3. North America market size and forecast, by application
7.2.4. North America market size and forecast, by drug formulation
7.2.5. North America market size and forecast, by country

7.2.5.1. U.S. market size and forecast, by type
7.2.5.2. U.S. market size and forecast, by application
7.2.5.3. U.S. market size and forecast, by drug formulation
7.2.5.4. Canada market size and forecast, by type
7.2.5.5. Canada market size and forecast, by application
7.2.5.6. Canada market size and forecast, by drug formulation
7.2.5.7. Mexico market size and forecast, by type
7.2.5.8. Mexico market size and forecast, by application
7.2.5.9. Mexico market size and forecast, by drug formulation

7.3. Europe

7.3.1. Key market trends and opportunities
7.3.2. Europe market size and forecast, by type
7.3.3. Europe market size and forecast, by application
7.3.4. Europe market size and forecast, by drug formulation
7.3.5. Europe market size and forecast, by country

7.3.5.1. France market size and forecast, by type
7.3.5.2. France market size and forecast, by application
7.3.5.3. France market size and forecast, by drug formulation
7.3.5.4. UK market size and forecast, by type
7.3.5.5. UK market size and forecast, by application
7.3.5.6. UK market size and forecast, by drug formulation
7.3.5.7. Italy market size and forecast, by type
7.3.5.8. Italy market size and forecast, by application
7.3.5.9. Italy market size and forecast, by drug formulation
7.3.5.10. Spain market size and forecast, by type
7.3.5.11. Spain market size and forecast, by application
7.3.5.12. Spain market size and forecast, by drug formulation
7.3.5.13. Rest of Europe market size and forecast, by type
7.3.5.14. Rest of Europe market size and forecast, by application
7.3.5.15. Rest of Europe market size and forecast, by drug formulation

7.4. Asia-Pacific

7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by type
7.4.3. Asia-Pacific market size and forecast, by application
7.4.4. Asia-Pacific market size and forecast, by drug formulation
7.4.5. Asia-Pacific market size and forecast, by country

7.4.5.1. Japan market size and forecast, by type
7.4.5.2. Japan market size and forecast, by application
7.4.5.3. Japan market size and forecast, by drug formulation
7.4.5.4. China market size and forecast, by type
7.4.5.5. China market size and forecast, by application
7.4.5.6. China market size and forecast, by drug formulation
7.4.5.7. India market size and forecast, by type
7.4.5.8. India market size and forecast, by application
7.4.5.9. India market size and forecast, by drug formulation
7.4.5.10. Australia market size and forecast, by type
7.4.5.11. Australia market size and forecast, by application
7.4.5.12. Australia market size and forecast, by drug formulation
7.4.5.13. South Korea market size and forecast, by type
7.4.5.14. South Korea market size and forecast, by application
7.4.5.15. South Korea market size and forecast, by drug formulation
7.4.5.16. Rest of Asia-Pacific market size and forecast, by type
7.4.5.17. Rest of Asia-Pacific market size and forecast, by application
7.4.5.18. Rest of Asia-Pacific market size and forecast, by drug formulation

7.5. LAMEA

7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by type
7.5.3. LAMEA market size and forecast, by application
7.5.4. LAMEA market size and forecast, by drug formulation
7.5.5. LAMEA market size and forecast, by country

7.5.5.1. Brazil market size and forecast, by type
7.5.5.2. Brazil market size and forecast, by application
7.5.5.3. Brazil market size and forecast, by drug formulation
7.5.5.4. South Africa market size and forecast, by type
7.5.5.5. South Africa market size and forecast, by application
7.5.5.6. South Africa market size and forecast, by drug formulation
7.5.5.7. Rest of LAMEA market size and forecast, by type
7.5.5.8. Rest of LAMEA market size and forecast, by application
7.5.5.9. Rest of LAMEA market size and forecast, by drug formulation

CHAPTER 8: COMPANY PROFILES

8.1. Algenol Biofuels Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio

8.2. Dongtai City Spirulina Bio-engineering Co, Ltd.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio

8.3. CHR. HANSEN HOLDING A/S

8.3.1. Company overview
8.3.2. CHR. Hansen: company Snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance

8.4. CYANOTECH CORPORATION

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance

8.5. DDW Inc.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio

8.6. DIC CORPORATION

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance

8.7. DÖHLER GMBH

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio

8.8. FMC CORPORATION

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. Givaudan International SA

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. KONINKLIJKE DSM N.V.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments

8.11. Prolgae

8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Operating business segments
8.11.4. Product portfolio
8.11.5. Business performance

8.12. SENSIENT TECHNOLOGIES CORPORATION

8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Operating business segments
8.12.4. Product portfolio
8.12.5. Business performance

8.13. E.I.D. Parry Limited

8.13.1. Company overview
8.13.2. Company snapshot
8.13.3. Operating business segments
8.13.4. Product portfolio
8.13.5. Business performance


【レポート販売概要】

■ タイトル:スピルリナの世界市場:種類別(アルスロスピラプラテンシス、アルスロスピラマキシマ)、用途別(栄養補助食品、化粧品、食品および飲料、動物飼料、その他)、製剤別(粉末、錠剤・カプセル、液体、顆粒、ゲル化剤)
■ 英文:Spirulina Market by Type (Arthrospira Platensis and Arthrospira Maxima), Application (Nutraceuticals, Cosmetics, Food & Beverages, Animal Feed, and Others), and Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日:2019年5月6日
■ 調査会社:Allied Market Research
■ 商品コード:AMR9AG003
■ 調査対象地域:グローバル
  • 接着剤及びシーラントの世界市場
    The report covers the global adhesives & sealants market and further segments the market on the basis of chemistry type, formulating technology, application, and region. The market data for these types is given with respect to volume (kilotons) and value ($million). The global market value of adhesives & sealants is estimated to be $45.36 billion in 2015 and is projected to grow at a CAGR of about …
  • アルファオレフィンの世界市場:1-ブテン、1-ヘキセン、1-オクテン、その他
    The alpha olefin market is projected to reach USD 19.85 Billion by 2020, registering a CAGR of 6.2% between 2015 and 2020. The global alpha olefin market is driven by increased demand from end-use industries such as plastics and automotive. Asia-Pacific, with its growing economy and rapidly expanding plastics and automotive industries, is projected to witness the highest growth in the alpha olefin …
  • 世界の塩素化ポリ塩化ビニル市場2015
    The Global Chlorinated Polyvinyl Chloride Industry Report 2015 is a professional and in-depth study on the current state of the CPVC industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The CPVC market analysis is provided for the international markets including development trends, competitive landscape an …
  • ピープロテインの世界市場2015-2022
    According to Stratistics MRC, the Global Pea Proteins Market is valued at $23.47 million in 2015 and is expected to grow at a CAGR of 9.2% to reach $43.45 million by 2022. Growing vegetarian population and high nutritional characteristic of pea protein are some of the major factors fueling the market growth. Increasing demand for meat alternatives and egg substitutes is poised to have a positive i …
  • てんかん重積状態治療のグローバル臨床試験動向(2014年下半期)
    Status Epilepticus Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Status Epilepticus Global Clinical Trials Review, H2, 2014" provides data on the Status Epilepticus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Status Epilepticus. It includes an overview of the trial numbers and their recruitme …
  • 平ガラスの世界市場分析:製品別(強化、ラミネート、基本フロート、断熱)、用途別(自動車、建設)、セグメント予測
    Global Flat Glass market is expected to reach USD 124.14 billion by 2022, according to a new study by Grand View Research, Inc. Rising awareness regarding benefits of glass usage in building & construction including safety, security and energy savings is expected to drive flat glass market over the forecast period. Product innovations in terms of improved characteristics coupled with introduction …
  • オフハイウェイ・商業用ハイブリッド車両用部品の世界市場
    Abstract The use of hybrid technology was prominent in passenger cars earlier; however, advances in technology have ensured its widespread adoption in vehicles other than passenger cars. Also, rise in fuel prices has shifted the focus of automakers toward this technology. The usage of hybrid technology in off-highway hybrid commercial vehicles is increasing. Many electronic and electrical componen …
  • アルツハイマー病:グローバル臨床試験レビュー(2014年上半期)
    Alzheimer's Disease Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Alzheimer's Disease Global Clinical Trials Review, H1, 2014" provides data on the Alzheimer’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alzheimer’s Disease. It includes an overview of the trial numbers and their recru …
  • Chronic Urticaria Or Hives:グローバル臨床試験レビューH1, 2013
    Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2013" provides data on the Chronic Urticaria Or Hives clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Urticaria Or Hives. It includes an overview of the t …
  • トリルトリアゾールの世界市場
    Tolyltriazole (CAS 29385-43-1) Market Research Report 2013 presents comprehensive data on tolyltriazole markets globally and regionally (Europe, Asia, North America etc.) The Tolyltriazole (CAS 29385-43-1) Market Research Report 2013 includes tolyltriazole description, covers its application areas and related patterns. It overviews tolyltriazole market, names tolyltriazole producers and indicates …
  • 民間航空機・軍用航空機用ヘッドセットの世界市場
    About Commercial Aviation and Military Headset Easy methods of communication has become imperative for the defense authorities to augment the capabilities of their armed forces. This is prompted the defense industry to embrace new communication technologies and transit to a new generation of sophisticated systems that enable faster, secure, cost-effective, and more flexible communications for well …
  • モルト・ウイスキーのグローバル市場動向と予測(~2018)
    The global market for single malt Scotch has hit a new high – selling some 7.8m cases (domestic and travel retail combined). This latest report from just-drinks/IWSR provides a complete market analysis of the global malt whisky sector, offering an expert review of the markets, brands, categories and companies. The report comments on such issues as: premiumisation - single malt is highly aspiration …
  • Tabalumab (Systemic Lupus Erythematosus and Lupus Nephritis):市場予測と分析(~2022)
    Tabalumab (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022 Summary Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations includes renal (kidney) involvem …
  • 自動車用調整可能ステアリングシステムの世界市場:手動調整可能ステアリング、電気的調整可能ステアリング
    Global Automotive Adjustable Steering System Market: About this market An automotive adjustable steering system improves the safety and comfort of the driver. Technavio’s automotive adjustable steering system market analysis considers sales from the manually adjustable steering and electrically adjustable steering segments. Our analysis also considers the sales of automotive adjustable steering sy …
  • 開閉器の世界市場:低圧開閉器、中圧開閉器、高圧開閉器
    About Switchgear A switchgear is defined as a combination of the following components: • Electrical disconnect switches • Circuit breakers • Protective relays • Other components such as disconnectors, busbars, enclosures, and fuses The use of switchgears enables the continuous transfer of electric current and protection against current overload, short circuit, and insulation failure. It provides s …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。